Stock Events

Stock Events

Regeneron Pharmaceuticals 

$899.75
881
-$33.36-3.58%Friday 08:42

Statistics

Day High
934.56
Day Low
890
52W High
972.98
52W Low
597
Volume
2,033
Avg. Volume
-
Mkt Cap
93.08B
P/E Ratio
-
Dividend Yield
0.42%
Dividend
3.76

Upcoming

Dividends

0.42%Dividend Yield
Dec 2026
$0.94
Aug 2026
$0.94
Jun 2026
$0.94
Mar 2026
$0.94
Dec 2025
$0.88
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
5.11%

Earnings

Jan 29Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
8.91
14.41
19.9
25.39
Expected EPS
25.390775
Actual EPS
N/A

Financials

31.41%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
14.34BRevenue
4.5BNet Income

Analyst Ratings

$897.59Average Price Target
The highest estimate is ⁦1,175.00⁩.
From 22 ratings within the last 6 months. This is not an investment recommendation.
Buy
68%
Hold
32%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow REGN.BOATS. It's not an investment recommendation.
Microsoft
248
MSFT
NVIDIA
247
NVDA
Amazon
218
AMZN
Apple
203
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes directly with Regeneron in the biotechnology sector, focusing on innovative therapeutics in areas like oncology and cardiovascular disease.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is a competitor in the biopharmaceutical field, particularly in antiviral drugs, which may overlap with Regeneron's infectious disease treatments.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie operates in similar therapeutic areas as Regeneron, including immunology and oncology, making it a direct competitor.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes in the biopharmaceutical space, focusing on cancer, HIV/AIDS, and cardiovascular diseases, areas that intersect with Regeneron's interests.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company with a broad product portfolio that includes immunology and oncology drugs, competing with Regeneron's offerings.
Merck
MRK
Mkt Cap368.89B
Merck is known for its strong presence in the pharmaceutical industry, including areas like cancer treatment and infectious diseases, making it a competitor to Regeneron.
Novartis
NVS
Mkt Cap303.67B
Novartis competes with Regeneron in multiple areas, including ophthalmology and immunology, with a strong focus on research and development.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, through its biotech division, competes in the oncology and immunology sectors, directly challenging Regeneron's market.
Sanofi
SNY
Mkt Cap106.24B
Sanofi collaborates with Regeneron on some projects but also competes in areas like immunology and rare diseases, making the relationship complex.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca is involved in biopharmaceuticals across several therapeutic areas, including respiratory, cardiovascular, and oncology, competing with Regeneron.

About

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
Show More
CEO
ISIN
US75886F1075

Listings

STU
DE
RGO.STU
MX
MX
REGN.MX
VI
AT
REGN.VI
MI
IT
1REGN.MI

0 Comments

Share your thoughts

FAQs

What is Regeneron Pharmaceuticals stock price today?▼
The current price of REGN.BOATS is $899.75 USD — it has decreased by -3.58% in the past 24 hours. Watch Regeneron Pharmaceuticals stock price performance more closely on the chart.
What is Regeneron Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Regeneron Pharmaceuticals stocks are traded under the ticker REGN.BOATS.
What is Regeneron Pharmaceuticals market cap?▼
Today Regeneron Pharmaceuticals has the market capitalization of 93.08B
When is the next Regeneron Pharmaceuticals earnings date?▼
Regeneron Pharmaceuticals is going to release the next earnings report on January 29, 2027.
What were Regeneron Pharmaceuticals earnings last quarter?▼
REGN.BOATS earnings for the last quarter are 20.07 USD per share, whereas the estimation was 16.51 USD resulting in a +21.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Regeneron Pharmaceuticals revenue for the last year?▼
Regeneron Pharmaceuticals revenue for the last year amounts to 14.34B USD.
What is Regeneron Pharmaceuticals net income for the last year?▼
REGN.BOATS net income for the last year is 4.5B USD.
Does Regeneron Pharmaceuticals pay dividends?▼
Yes, REGN.BOATS dividends are paid quarterly. The last dividend per share was 0.94 . As of today, Dividend Yield (FWD)% is 0.42%.
In which sector is Regeneron Pharmaceuticals located?▼
Regeneron Pharmaceuticals operates in the Other sector.
When did Regeneron Pharmaceuticals complete a stock split?▼
Regeneron Pharmaceuticals has not had any recent stock splits.